Goldman Sachs Upgrades Aviv REIT (AVIV) to Buy

Goldman Sachs upgraded Aviv REIT (NYSE: AVIV) from Neutral to Buy with a price target of $29.00 (from $25.00) citing the best spread investment growth in their coverage.

Analyst Andrew Rosivach states, "Aviv’s business model – purchasing small-sized skilled nursing portfolios – is underappreciated by the market and can have a meaningful impact on Aviv’s small earnings base. We believe Aviv can trade at a closer relative AFFO multiple to REIT peers given a growth rate near the sector average. Our $29, 12-month price target is based on a 20% discount to our coverage multiple of 15x 2018E AFFO. This discount is due to greater risk from AVIV’s SNF asset mix."

For an analyst ratings summary and ratings history on Aviv REIT click here. For more ratings news on Aviv REIT click here.

Shares of Aviv REIT closed at $25.29 yesterday.

You May Also Be Interested In

• Marvell (MRVL) PT Raised to $225 at TD Cowen
• Benchmark Reiterates Speculative Buy Rating on Nephros (NEPH) Following Strong Q2 Results
• CrowdStrike (CRWD) PT Raised to $250 at Benchmark Ahead of Q2 Results